We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Rhythm Pharmaceuticals
RYTM
$7.96B
| $987K | ﹤0.01% |
40,290
-915
| -2% | -$17K |
|
2727
Microvast
MVST
$302M
| $984K | ﹤0.01% |
543,283
+2,395
| +0.4% | +$5.72K |
|
2728
Miller Industries
MLR
$619M
| $981K | ﹤0.01% |
46,070
+1,225
| +3% | +$28.3K |
|
|
KBAL
2729
DELISTED
Kimball International
KBAL
| $980K | ﹤0.01% |
155,935
-948
| -0.6% | -$7.36K |
|
2730
Universal Electronics
UEIC
$61.3M
| $978K | ﹤0.01% |
49,746
-870
| -2% | -$20.6K |
|
2731
First Bancorp
FNLC
$399M
| $976K | ﹤0.01% |
35,406
-1,716
| -5% | -$50.8K |
|
2732
Tarsus Pharmaceuticals
TARS
$2.84B
| $976K | ﹤0.01% |
57,018
-2,052
| -3% | -$32.6K |
|
|
VLTA
2733
DELISTED
Volta Inc.
VLTA
| $975K | ﹤0.01% |
806,128
+467,289
| +138% | +$948K |
|
2734
Allient
ALNT
$1.92B
| $969K | ﹤0.01% |
33,875
-869
| -3% | -$25.9K |
|
2735
GrowGeneration
GRWG
$90.7M
| $969K | ﹤0.01% |
277,002
-7,548
| -3% | -$34.8K |
|
2736
Community Health Systems
CYH
$423M
| $965K | ﹤0.01% |
449,005
-1,648,413
| -79% | -$5.46M |
|
2737
5E Advanced Materials
FEAM
$62.3M
| $965K | ﹤0.01% |
4,131
-20
| -0.5% | -$7.08K |
|
|
LONA
2738
LeonaBio Inc
LONA
$72.1M
| $961K | ﹤0.01% |
11,379
+258
| +2% | +$8.9K |
|
2739
Comtech Telecommunications
CMTL
$51.8M
| $959K | ﹤0.01% |
95,854
+2,432
| +3% | +$26.8K |
|
|
PCSB
2740
DELISTED
PCSB Financial Corporation
PCSB
| $942K | ﹤0.01% |
52,526
-7,821
| -13% | -$149K |
|
|
DNMR
2741
DELISTED
Danimer Scientific, Inc.
DNMR
| $941K | ﹤0.01% |
7,975
+217
| +3% | +$38.7K |
|
2742
BCB Bancorp
BCBP
$161M
| $940K | ﹤0.01% |
55,839
-146
| -0.3% | -$2.69K |
|
2743
KB Financial Group
KB
$43.5B
| $938K | ﹤0.01% |
31,116
+7,172
| +30% | +$259K |
|
|
TPC
2744
Tutor Perini Cor
TPC
$5.21B
| $937K | ﹤0.01% |
169,795
-6,513
| -4% | -$49.4K |
|
2745
ThredUp
TDUP
$422M
| $936K | ﹤0.01% |
508,725
+105,242
| +26% | +$264K |
|
2746
Tredegar Corp
TG
$310M
| $934K | ﹤0.01% |
98,877
-7,145
| -7% | -$73.7K |
|
2747
FVCBankcorp
FVCB
$333M
| $933K | ﹤0.01% |
60,799
+639
| +1% | +$9.79K |
|
|
NPKI
2748
NPK International
NPKI
$1.14B
| $932K | ﹤0.01% |
370,168
-5,847
| -2% | -$17.2K |
|
2749
Omega Flex
OFLX
$312M
| $931K | ﹤0.01% |
10,051
-39
| -0.4% | -$4.26K |
|
|
HDSN
2750
Hudson Technologies
HDSN
$235M
| $926K | ﹤0.01% |
125,981
+797
| +0.6% | +$6.7K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.